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CHAPTER 1
BACKGROUND
Structure and Function of Striated Muscle
Muscle is a contractile tissue that is responsible for a variety of body movements via the
ability to convert ATP into mechanical energy (Marieb & Hoehn, 2013). There are three types
of muscle: skeletal, cardiac and smooth muscle. Around 40% of the human body mass is
skeletal muscle while another 10% is smooth and cardiac muscle (Hoyle, 1969; Hall & Guyton,
2011). Skeletal muscle is attached to the skeleton and primarily responsible for voluntary
movement. Cardiac muscle is primarily found in in the heart where it constitutes the majority
of the chamber walls. Smooth muscle is found in hollow visceral organs such as the stomach,
the urinary bladder and the vasculature, and plays a role in the facilitation of fluid and substance
motility (Hall & Guyton, 2011).
Both skeletal muscle and cardiac muscle are classified as striated muscle, due to the
visible striations under a light microscope (A. F. Huxley & Niedergerke, 1954; H. Huxley &
Hanson, 1954; Hanson, 1968). To give a background of my thesis study, this chapter will focus
on striated muscle and the function of troponin T (TnT) in the regulation of striated muscle
contraction.
Overall Organization of Striated Muscle Cells
Striated muscle consists of myocytes or muscle fibers, which are in turn comprised of
myofibrils.

These myofibrils contain contractile units called sarcomeres that consist of

myofilaments including the actin thin and myosin thick filaments. The actin thin filaments and
myosin thick filaments overlap and are integrated together in an array to comprise the
sarcomere (Figure 1). During contraction and relaxation of muscle, the actin and myosin
filaments slide along each other to alter lengths of the sarcomere (H. E. Huxley, 1990). Under
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the light microscope, dark anisotropic bands (A-bands) occur where the thin and thick filaments
overlap. Light isotropic bands (I-bands) solely consist of thin filaments are present in areas of
non-overlapping with the thick filaments. Both the A and I bands repeat along the length of the
myofibril to create the visible striations under the light microscope (A. F. Huxley &
Niedergerke, 1954; H. Huxley & Hanson, 1954; Hanson, 1968; Marieb & Hoehn, 2013).

Figure 1 - Organization of striated muscle (OpenStax College, CC BY-SA 3.0)
The thick filaments contain myosin and extend the entire length of the A band (Figure 1)
while the thin filaments containing actin extend the length of the I-band, and also partly into the
A-band. The Z-disc (Z-lines), mostly comprised of alpha-actinin, defines the border of the
individual sarcomeres, and is responsible for anchoring the thin filaments (H. Huxley &
Hanson, 1954; Ebashi & Ebashi, 1965; Maruyama & Ebashi, 1965; Hanson, 1968; Hall &
Guyton, 2011).
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Striated Muscle Myofilaments
Contraction of striated muscle relies on the interactions of the thin and thick filaments.
Thick filaments are around 16 nm in diameter and contains around 300 myosin molecules.
Each myosin molecule consists of four light and two heavy polypeptide chains, and contains
three domains: the head, neck and tail (Figure 2). The head domain binds to the actin in the thin
filament to form a cross-bridge, will allows force generation via ATP hydrolysis. The neck
domain of myosin associates with several light-chain regulatory subunits and the tail domain
affects the specific function of myosin within cells (Gazith, Himmelfarb, & Harrington, 1970;
Marieb & Hoehn, 2013).
The thin filament is primarily composed of actin. This 42 kDa protein is found in the
thin filament as globular actin (G actin,) which polymerizes to form two intertwined of fibrous
actin (F actin). F actin is comprised of approximately multiple actin monomers (Hanson &
Lowy, 1963; Holmes, Popp, Gebhard, & Kabsch, 1990; Herman, 1993), Tropomyosin (Tm) and
the troponin complex are also proteins located within the thin filament that are involved in
striated muscle contraction. Tropomyosin is a rod-shaped molecule containing a 40 nm coiled
units of two parallel dimeric chains, similar to that of a myosin tail. Tropomyosin is almost
always found physiologically as a dimer, and these dimers may comprise of different
tropomyosin isoforms. Muscle tissue usually contains α/β heterodimers with the exception of
cardiac muscle that expresses only a single α-Tm isoform (Gimona, Watakabe, & Helfman,
1995). The two strands of tropomyosin molecules run diametrically opposed along the actin
filaments and help stiffen and stabilize the thin filament. Each tropomyosin dimer is in contact
with seven actin units and are arranged end to end along the actin filaments (Figure 2). In a
relaxed muscle fiber, they block the myosin-binding sites on actin so that myosin heads on the
thick filaments cannot bind to the thin filaments (Ebashi & Ebashi, 1965; Marieb & Hoehn,
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2013).

Figure 2 – The striated muscle myofilaments (OpenStax College, CC BY-SA 3.0)
Titin is a giant protein around 3000 kDa that connects the Z line to the M line in the
sarcomere (Figures 3 & 4) (K. Wang, McClure, & Tu, 1979; Horowits, Kempner, Bisher, &
Podolsky, 1986). Titin’s role is to function as a molecular spring and scaffold by regulating the
sarcomere tension via contributing to the overall passive tension in striated muscle(Horowits et
al., 1986; Linke et al., 1997; Jin, 2000; Sanger & Sanger, 2001). Titin is modular in structure as
around 90% of its mass consists of repeating fibronectin-III and immunoglobulin-C2 domains
and which provide binding sites for a variety of myofibrillar proteins, such as actin, α-actinin,
myosin, telethonin, myosin binding protein-C myomesin, and obscurin (Pfuhl & Pastore, 1995;
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Rief, Gautel, Schemmel, & Gaub, 1998; Sanger & Sanger, 2001) .
Nebulin is another giant protein (600-900 kDa) only found in skeletal muscle (Figure 3)
that associates with the thin filament (Horowits et al., 1986; K. Wang & Wright, 1988).
Nebulin is mostly compromised of 35 residue repeats that allows a tight association with the
thin filament via a central consensus sequence of SDxxYK (Jin & Wang, 1991). Each actin
polymer is associated with two nebulin molecules, with each nebulin filament spanning the
length of the actin monomer within the thin filament. Nebulin binds to other actin-associated
proteins such as tropomyosin, which indicates that nebulin is well integrated into the thin
filament. Nebulin’s close association with the thin filament allows it to stabilize the thin
filament and modulate thin filament length (K. Wang & Wright, 1988; Jin & Wang, 1991; Ogut,
Hossain, & Jin, 2003; Castillo, Nowak, Littlefield, Fowler, & Littlefield, 2009). In cardiac
muscle, nebulette (Figure 4) is an 800 kDa protein that exhibits high homology with nebulin and
fulfills similar roles such as sarcomere assembly and contractile function (Moncman & Wang,
1995; Ogut et al., 2003).

Figure 3 - Organization of the skeletal muscle sarcomere. Retrieved
http://www.pradeepluther.com/pklwork19may02/images/Sarcomere_diagram.jpg

from
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Figure 4 - Organization of the cardiac sarcomere, modified from (Veselka, 2012).
Striated Muscle Contraction
In 1954, the molecular basis of muscle contraction was described by two groups: A. F.
Huxley and R. Niedergerke and H. E. Huxley and J. Hanson (A. F. Huxley & Niedergerke,
1954; Hoyle, 1969).

Their findings described the relative positions of myosin and actin

filaments during various stages in muscle contraction, and how these interactions resulted in the
production of contractile force. Under the microscope, it was shown that the length of the Aband does not change during muscle contraction. However, it was found that the I-band, rich in
actin thin filaments, changed its length along with the sarcomere (A. F. Huxley & Niedergerke,
1954; H. Huxley & Hanson, 1954). Based on these observations, the sliding filament theory
was developed, which proposes that the sliding of actin past myosin generates muscle tension.
Since the actin thin filaments are anchored to the Z-disc, shortening of the thin filament results
in increased overlapping of the thin and thick filaments and subsequent shortening of the
sarcomere, which ultimately results in the shortening of the muscle (Hoyle, 1969).
Muscle contraction on the molecular level occurs when the myosin head on the thick
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filament attaches to an actin filament to form a cross-bridge (Figure 5). Then, the myosin head
rotates toward the myosin tail, which pulls on the thin filament, causing the thin filament to
move relative to the thick filament (power stroke). The myosin head detaches and rotates back
to the initial orientation, completing one cross-bridge cycle. This process is coupled with ATP
hydrolysis catalyzed by the ATPase activity of the myosin head during its interaction with actin
in the thin filament (Ebashi & Ebashi, 1965; Vale & Milligan, 2000; Volkmann & Hanein,
2000; Goody, 2003).
When striated muscle is relaxed, the cross-bridges are unattached and the myosin heads
on the thick filaments are at a 90 degrees angle in regards to the thin filaments (Figure 5, step
2). In this relaxed state, the myosin head is ATP-bound. When intracellular Ca2+ increases
upon the stimulation of muscle contraction, Ca2+ binds to troponin and induces a conformational
change in tropomyosin, which exposes the myosin binding sites on the actin thin filaments
(Ebashi, 1963; Potter & Gergely, 1974; Zot & Potter, 1987). The myosin head is then able to
weakly bind to the actin thin filament to form a cross-bridge (Figure. 5, step 3). The inorganic
phosphate is then released in order to facilitate a strong attachment between actin and myosin.
Because of this strong attachment, the myosin heads rotate at a 45 degree angle towards actin
(Figure 5, step 4), generating a force on the thin filaments which results in the thin filaments to
slide relatively to the thick filaments to generate the power stroke. Next, ADP disassociates
from the myosin head and the subsequent binding of ATP causes the cross-bridge to detach (Fig
5, step 1) (Hall & Guyton, 2011; Marieb & Hoehn, 2013). Hydrolysis of ATP to ADP and Pi
by the myosin-ATPase returns the myosin head’s orientation to 90 degrees relative to the thin
filament (Figure 5, step 2). This cycle is repeated as long as the intracellular Ca2+ concentration
remains sufficiently elevated (Goody, 2003).
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Figure 5 – The Cross-bridge cycle (Goody, 2003). AF: Actin filament, MF: Myosin filament
Regulation of Striated Muscle Contraction
Striated muscle contraction is regulated by intracellular Ca2+ concentration via the thin
filament regulatory proteins, i.e., the troponin complex and tropomyosin. In the absence of
intracellular Ca2+, the interaction of myosin with actin is inhibited due to the unexposed myosin
binding sites on the actin thin filaments. After the intracellular Ca2+ concentration increases due
to Ca2+ release from the sarcoplasmic reticulum, Ca2+ binds to the troponin complex, which
reconfigures the position of tropomyosin and exposes the myosin binding sites on the actin thin
filament, allowing the binding of the myosin head to actin to initiate cross-bridge cycling
(Gomes, Potter, & Szczesna-Cordary, 2002; Goody, 2003).
Structure of the Troponin Complex
By the 1960’s Ebashi and colleagues identified a mixture of proteins that induced
muscle relaxation when the mixture and ATP was added to muscle fibers (Ebashi, 1963; Ebashi
& Endo, 1968; Potter & Gergely, 1974; Zot & Potter, 1987; Endo, 2008). This relaxing factor
was later discovered to the proteins that make up the troponin complex. The troponin complex
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consist of three protein subunits: Troponin C (TnC), the calcium sensor, Troponin I (TnI),
which binds to actin, and Troponin T (TnT), which anchors the troponin complex to
tropomyosin (Figure 6).

The overall role of troponin is to regulate the contraction and

relaxation of striated muscle. When the muscle is relaxed, TnI is bound to actin and blocks the
myosin binding sites on actin (Drabikow.W & Nonomura, 1968; Spudich, Huxley, & Finch,
1972; Drabikow.W, Nowak, Barylko, & Dabrowsk.R, 1973; Vaneerd & Kawasaki, 1973;
Dabrowska, Nowak, Podlubnaya, & Drabikowski, 1975). Thus, TnI-actin interactions are a
regulatory mechanism to prevent cross-bridge formation and subsequent muscle contraction
(Nakaoka, 1972; Yamamoto & Maruyama, 1973; Dabrowska, Podlubnaya, Nowak, &
Drabikowski, 1976; Dowben, Ford, & Bunting, 1976). Upon an increase in intracellular Ca2+,
Binding of Ca2+ to TnC leads to a conformation change between the switch region of TnI and a
hydrophobic patch in TnC’s N-terminal region. This interaction between TnI and TnC releases
TnI’s inhibition of cross-bridge formation by pulling TnI’s inhibitory region away from actin
and consequently allowing the myosin head to bind to actin (Gomes, Potter, et al., 2002; Goody,
2003; Endo, 2008).

Figure 6 – The troponin complex (Sheng & Jin, 2014)
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Troponin T
Molecular Structure and Function
Troponin T is a 30-35 kDa protein whose difference in size can be attributed to the
variable length of the N-terminal region. Even though a basic function of TnT is to anchor the
troponin complex to tropomyosin, the variable structure of TnT across isoforms has various
physiological and pathological implications in muscle function (Schachat, Diamond, & Brandt,
1987; Pan & Potter, 1992; Anderson et al., 1995; Fisher, Wang, & Tobacman, 1995; Briggs &
Schachat, 1996; Watkins, Seidman, Seidman, Feng, & Sweeney, 1996; J. Wang & Jin, 1998;
Huang, Brozovich, & Jin, 1999; Jin, Chen, Ogut, & Huang, 2000; Zhang, Biesiadecki, & Jin,
2006; Biesiadecki, Chong, Nosek, & Jin, 2007). TnT is present in vertebrates in slow skeletal,
fast skeletal and cardiac muscle isoforms with greatest variation in the N-terminal region across
isoforms (Figure 7) (Hoyle, 1969; Mak & Smillie, 1981; Leavis & Gergely, 1984; Jin & Lin,
1988). TnT’s rather conserved C-terminal region contains binding sites for TnC, TnI, and Tm
while the also conserved middle region contains a binding site for tropomyosin (site 1) (Mak &
Smillie, 1981; Leavis & Gergely, 1984; Morris & Lehrer, 1984; Heeley, Golosinska, & Smillie,
1987; Zot & Potter, 1987; Jin & Chong, 2010).
Several decades ago, it was demonstrated that chymotrypsin treatment results in two
TnT fragments named T1 (equivalent to the cyanogen bromide (CNBr) cleaved fragment CB1)
and T2 that each contain a tropomyosin binding site (Pearlstone, Carpenter, & Smillie, 1977;
Mak & Smillie, 1981; Morris & Lehrer, 1984; Heeley et al., 1987). The T1 fragment containing
site 1 consists of amino acids 2-158 in rabbit fast skeletal muscle TnT while the T2 fragment
containing site 2 consists of amino acids 159-259. T1 region tropomyosin binding site has been
further localized (Figure 8) to amino acids 117–143 in mouse cardiac TnT (exon 10) and 72–97
in rabbit fast TnT (exon 11).
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Since there is limited crystal structure data only pertaining to TnT’s C-terminal region,
TnT’s two binding sites have only been recently mapped out (Takeda, Yamashita, Maeda, &
Maeda, 2003; Jin & Chong, 2010). In previous literature, TnT’s Tm binding site on the Cterminal region has been hypothesized to be located on the very end of the C-terminal.
However, this assertion has not been supported by experiments showing that deletion in the
very C-terminal end does not significantly affect Tm binding or ATPase activity (Jha, Leavis,
& Sarkar, 1996; Jin, Chong, & Hossain, 2007). Rather, the T2 region binding site has recently
been localized to amino acids 180–204 in slow TnT (exon 11), and 174-198 in rabbit fast
skeletal muscle (exon 14), which indicates that the T2 region binding site is actually located
towards the beginning of the T2 region (Figure 6 & 8). Both the middle and the T2 Tm binding
sites are highly conserved muscle-fibre specific cross isoforms (Jin & Chong, 2010).

Figure 7 – Structure of TnT isoforms. The TnT isoforms has a conserved core region and Cterminal region with the greatest difference in the N-terminal region (Jin & Chong, 2010)
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Figure
8
–
Sequence
alignment of Tm binding sites
1 and 2 across TnT isoforms.
Both Tm binding sites are
highly
conserved.
The
numbers
of
homologous
exons
encoding
these
segments are shown in the
background while Identical or
conserved residues encoded
by the two Tm-binding sites
main coding exons are
outlined with the gray bars
above the sequences (Jin &
Chong, 2010)

Muscle Type Specific Isoforms of TnT
TNNT1, TNNT2, and TNNT3 are three homologous genes of TnT that encode
respectively the slow, cardiac and fast isoforms of TnT. These TnT isoforms are expressed
specifically in their respective muscle fibers in a non-redundant manner (Cooper & Ordahl,
1985; Breitbart & Nadalginard, 1986; Anderson et al., 1995; Jin, Chen, & Huang, 1998), as it
has been shown that knockout of the cardiac TnT gene results in embryonic lethality (Nishii et
al., 2008). The three muscle fiber-type specific TnT isoforms have the greatest diversity in their
N-terminal hypervariable region (Figure 7). It is important to note that the diversity of TnT
isoforms is greater across isoforms than that within the same isoform across species (Figure 9)
(Verin & Gusev, 1988; Mesnard et al., 1995; Chandra, Kim, & Solaro, 1997; Jin & Root, 2000;
Gomes, Guzman, Zhao, & Potter, 2002; Feng, Biesiadecki, Yu, Hossain, & Jin, 2008; Chong &
Jin, 2009). This feature suggests that the N-terminal hypervariable region has a muscle fiberspecific role in regulating the function of TnT, and consequently, the function of specific
muscle fiber types.
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Figure 9 - Evolutionary
lineage of TnT isoforms.
Sequence divergence show
that TnT isoforms vary
greater across isoforms than
between
species.
The
evolutionary distances are
indicated with a ruler bar for
the rate of amino acid
substitution (Modified from
Chong & Jin, 2009)

The N-terminal Hypervariable Region of TnT
TnT’s N-terminal hypervariable region does not bind to any other thin filament proteins
and its absence does not abolish the binding of TnT to tropomyosin. Deletion of the N-terminal
region from cardiac TnT has been observed not to abolish but to increase TnT’s overall binding
affinity for tropomyosin, suggesting that the N-terminal region is a regulatory structure of TnT
(Verin & Gusev, 1988; Pan, Gordon, & Potter, 1991; Jin et al., 2000; Jin & Root, 2000;
Biesiadecki et al., 2007; Feng et al., 2008). Furthermore, it has been observed that the Nterminal variable region in TnT is regulated by alternate RNA splicing during muscle
development and other physiological conditions, which suggests that the modulatory structure
of the N-terminal region is a site that regulates muscle function via the modulation of TnT’s
structure and function (Breitbart et al., 1985; Cooper & Ordahl, 1985; Breitbart & Nadalginard,
1987; Gahlmann, Troutt, Wade, Gunning, & Kedes, 1987; Jin, Huang, Yeh, & Lin, 1992;
Akella, Ding, Cheng, & Gulati, 1995; Anderson et al., 1995; Briggs & Schachat, 1996; Wei &
Jin, 2011).
Alternate splicing of the N-terminal variable region during muscle development has been
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shown to alter force production in skinned fibers and aberrant splicing of this region has been
correlated with various cardiomyopathies such as dilated cardiomyopathy and other cardiac
dysfunctions (Jin & Lin, 1988; Anderson et al., 1995; Wei & Jin, 2011; Feng, Chen, Nan,
Huang, & Jin, 2014). Alternate splicing of fast TnT (fTnT) has been observed to generate
acidic and basic isoforms of TnT with significantly different binding affinities to Tm and TnI,
indicating that the charge of the N-terminal region contributes to the TnT’s overall binding to
Tm and TnI (J. Wang & Jin, 1997; Ogut, Granzier, & Jin, 1999; Biesiadecki et al., 2007).
Because the N-terminal region is able to alter TnT’s binding to TnI and Tm, of which the
binding sites are remotely located, it was hypothesized that the N-terminal region might affect
the overall conformation of TnT. This hypothesis was supported by epitope analysis data
showing that alterations in the N-terminal region is propagated to the core and C-terminal
regions (J. Wang & Jin, 1998; Jin et al., 2000). Even though it is known that the N-terminal
region can modulate TnT’s binding affinity to Tm, it is still unclear to what extent and how each
of TnT’s tropomyosin binding sites contribute to the overall binding affinity to Tm.
Hypothesis and Goal of the Present Study
Although TnT’s C-terminal domain and middle region is very much conserved, the Nterminal region is hypervariable (Figure 7), and varies significantly across isoforms and plays a
modulatory role in the Ca2+ regulation of muscle contraction.

The N-terminal region

contributes to the fine-tuning of Ca2+ regulation of contractility, as it has been observed that the
activity of myosin ATPase varies across TnT isoforms despite the conserved core structure of
TnT (Gomes, Guzman, et al., 2002). An unresolved discrepancy in the literature shows variable
differences in tropomyosin binding when comparing the T1 and T2 fragments of different TnT
isoforms. The fast TnT T1 fragment has been shown to have greater or equal affinity for Tm
compared to the fast TnT T2 fragment, while the slow TnT T1 has been observed to have a
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significantly lower binding affinity to Tm compared to slow TnT T2 (Pearlstone & Smillie,
1982; Heeley et al., 1987; Jin & Chong, 2010). This discrepancy in the literature may be
attributed to the modulatory function of the N-terminal region that is variable among musclefiber specific isoforms. The N-terminal hypervariable region of TnT may affect the affinity of
tropomyosin binding sites 1 and 2 across isoforms by changing the overall molecular
conformation, as it is already known that there are differences in binding site affinity across
isoforms despite conserved core structure. To investigate this hypothesis in this thesis study,
TnT fragments will be engineered, expressed and purified, and tropomyosin binding affinity
will be evaluated in enzyme-linked immunosorbent assay (ELISA)-based solid phase protein
binding experiments.

Understanding to what extent the N-terminal hypervariable region’s

structure affects the affinities of the tropomyosin binding sites of TnT will deepen and further
our understanding of how conformational changes in TnT affect tropomyosin-thin filament
interactions, thus modulating contractile properties of striated muscle under a variety of
physiological and pathological conditions.
The overall goal of this thesis project is to compare the tropomyosin binding affinities of
intact TnT and TnT fragments from different muscle fiber-specific isoforms to understand the
effect of the N-terminal region on tropomyosin binding affinity of the middle binding site of T1
(site 1). This study will also be able to explain the previous discrepancies in the literature that
show variable Tm binding affinities of the T1 fragments when compared to their respective T2
fragments (Pearlstone & Smillie, 1982; Heeley et al., 1987; Jin & Chong, 2010). To investigate
this issue, five sets of tropomyosin binding assays will be conducted, comparing intact TnT, T1
and T2 fragments across muscle fiber specific isoforms, as well as N-terminal truncated T1
fragments (middle fragments) across isoforms to examine the tropomyosin binding affinity of
site 1 without the influence of the N-terminal region. The last binding assay set will compare
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intact TnT and the various TnT fragments within the same isoform and same species in order to
understand how the intrinsic affinity of each Tm binding site differs within the same protein as
well as the effect of the N-terminal hypervariable region on site 1. The intact TnT and TnT
fragments studied in the present research are summarized in Figure 10.

Figure 10 – TnT constructs used in this study
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CHAPTER 2
METHODS
Methodology Overview
To meet the goals of this thesis project, a variety of basic science and biochemical
techniques are employed (Figure 11). In order to understand the Tm binding affinities within
the intact TnTs and TnT fragments, vectors expressing the coding cDNA were generated, and
proteins were purified from transformed bacterial cultures using various chromatographic
techniques. The protein preparations were verified for their authenticity and used in solid-phase
microtiter plate assays to examine their binding affinities to Tm.
Figure 11 – General
biochemical
techniques used in this
study

Protein Engineering and Purification
The purification steps for each protein used in this study are described below. Some
protein preparations were previously made in Dr. Jin’s laboratory and available for the present
study while some needed further purification.

For some of the proteins, there was no

engineered coding cDNA available and therefore the insert was generated using recombinant
polymerase chain reaction (PCR) from cDNA template and then cloned into a vector for protein
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expression (Table 1).
Table 1 – Summary of Protein Purification
Intact TnT
TnT Protein
Techniques
Used

Mouse Cardiac
Already available

TnT T1 Fragments
TnT Protein
Mouse Cardiac T1
Techniques
 Primer design for PCR amplification
Used
of insert from intact cDNA
 Cloning into insert
 Bacterial expression
 Ammonium sulfate precipitation
 Affinity chromatography
TnT Middle Fragments
TnT Protein
Mouse Cardiac Middle
Techniques
 Primer design for PCR amplification
Used
of insert from intact cDNA
 Cloning into insert
 Bacterial expression
 Ammonium sulfate precipitation
 Affinity chromatography

TnT T2 Fragments
TnT Protein
Mouse Cardiac T2
Techniques
 Primer design for PCR amplification
Used
of insert from intact cDNA
 Cloning into insert
 Bacterial expression
 Ammonium sulfate precipitation
 Affinity chromatography

Mouse Slow
 Bacterial expression
Ammonium sulfate
precipitation
 Anion exchange
chromatography (DE52)
 Size exclusion
chromatography (G75)
Human Slow T1
Already available

Mouse Slow Middle
Already available

Mouse Slow T2
Already available

Rabbit Fast
 Size exclusion
chromatography
(G75) of impure
protein fraction

Rabbit Fast T1
Already available

Mouse Fast Middle

 Primer design for
PCR amplification
of insert from
intact cDNA
 Cloning into insert
 Bacterial
expression
 Ammonium sulfate
precipitation
 Affinity
chromatography
Rabbit Fast T2
Already available

Analytical Methods
Agarose Gel Electrophoresis
Agarose gels were casted and run in Tris-Borate-EDTA (TBE) buffer, with a final
concentration of 0.34 mcg/mL ethidium bromide (EtBr). Based on the size of the DNA to be
visualized on the gel, different concentrations of agarose was used in order to obtain the most
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optimum resolution. For linear double stranded DNA (dsDNA) 800 to 12,000 base pairs (bp),
0.6% (w/v) gels were casted, and for dsDNA 500-10,000 bp, 200-3,000 bp, 1% (w/v) and 1.5%
(w/v) agarose were used, respectively. Samples were loaded after adding bromophenol blue
tracking dye and glycerol to a final concentration of 10% and the gel was run at a constant
voltage of 5-10V/cm in a horizontal tank.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was used with a Bio-Rad mini-gel system for the analysis of protein
samples. 14% resolving gels containing acrylamide/bis-acrylamide at the ratio of 180:1 were
used to resolve proteins of 30 kDa or greater and 12% gels containing acrylamide/bisacrylamide at the ratio of (29:1) were used to resolve proteins 10-30 kDa for optimum
separation of protein bands. Protein samples were homogenized in SDS-PAGE sample buffer
containing 2% SDS. After being heated at 80°C for 5 min, the samples were clarified by
spinning in a Beckman Coulter Microfuge 18 at 14,000 rpm (14,539 x g) at room temperature
(RT) for 5 min. The samples were then loaded into the gel and the gels were run with a
constant current of 25 mA/0.75 mm of SDS-PAGE gel. After running, the gel was fixed and
stained in Coomassie Brilliant Blue R250 in 50% methanol and 10% acetic acid for 45 minutes
and destained in 10% acetic acid to reveal the resolved protein bands.
Western Blot
Nitrocellulose (NC) membrane, thin and thick filter papers were soaked in transfer
buffer (Tris-glycine buffer and 20% methanol) for 30 minutes on an orbital shaker at 65 rpm.
After the SDS-PAGE gels finished running, the gel was placed in a “transfer sandwich”
(thick/thin filter paper-gel-NC membrane-thin/thick filter paper, from top to bottom) in a BioRad Laboratory semidry electrotransfer apparatus. The current limit was set to 5 mA per cm2
and the maximum voltage was set to 25 V during the 15 minutes of transfer.
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The membrane was then incubated in blocking buffer (1% bovine serum albumin (BSA)
Tris-buffered saline (TBS)) at room temperature for 30 minutes on a rocker. After blocking, the
membrane was incubated with the appropriate primary antibody diluted in TBS containing 0.1%
BSA at a pre-tested concentration on a rocker at 4°C overnight.
After the primary antibody incubation, the membrane was washed 3 times in TBS
containing 0.5 Triton X-100 and 0.1% SDS at 80 rpm on a rotator for 7 minutes per wash. The
membrane was then washed 2 times with TBS for 3 minutes per wash. After the washing step,
the membrane was placed in TBS containing 0.1% BSA with the final concentration of 1:10,000
of alkaline phosphatase conjugated goat anti-mouse IgG second antibody at RT on the rotator
for 50 min. After second antibody incubation, the above washing procedure was repeated.
For development of the substrate reaction, 10 mL of alkaline phosphatase buffer with 5Bromo-4-chloro-3-indolyl phosphate (3.3 mg/mL) and Nitro blue tetrazolium was used to
develop the membrane at room temperature in a cardboard box to avoid light exposure. The
membrane was developed until the target protein band was clearly seen but not oversaturated
(optimally 10-15 min).
For visualization of agarose gels, a UV transiluminator was initially used to confirm
optimal separation.

After good separation, the gels were again placed on the UV

transiluminator and photographed with a 2 second exposure time using a FinePix S7000 camera.
UV and Light Spectrometry
For visible and UV light spectrometry, two different spectrophotometers were used. A
BioRad SmartSpec spectrophotometer was used to quantify the absorbance of bacterial cultures
at OD600. 1 mL of growth media before inoculation was used a blank for baseline control and 1
mL of bacterial culture was used to monitor bacterial growth during large scale protein
purification.

For estimation of protein concentrations, a Beckman Coulter DU 520
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spectrophotometer was used. A Beckman Coulter microcell containing 100 µL of 1x ELISA
buffer (see ELISA protocol) for baseline control. Then, the protein in 1x ELISA buffer was
loaded into a clean microcell and then scanned with the spectrophotometer across wavelengths.
The absorbance value at 280 nm was recorded, and the concentration of the protein was
calculated using the Beer-Lambert law by using the calculated extinction value obtained from
the ExPASY database (Artimo et al., 2012).
Molecular Cloning
Design of Troponin T Fragments
DNA sequences of the mouse cardiac TnT (McTnT) T1, McTnT T2, mouse fast TnT
(MfTnT) middle and McTnT middle fragments were amplified from their respective intact
complementary DNA (cDNA) sequences. To obtain the coding cDNA fragment, forward and
reverse PCR primers were constructed flanking the target sequence.

The forward primer

contained an NdeI restriction enzyme cutting site and a Met initiation codon and the reverse
primer contained a stop codon prior to an EcoRI restriction site to facilitate the ligation of the
insert into the expression vector.

The primers were synthesized at Integrated DNA

Technologies.
Primer Sequences
McTnT T1:
Forward: 5’ CA CAT ATG TCK GAC VYV GAR GAR GWG GTG G 3’
Nde1
Reverse: 5’ CTC TGT CTT GAA TTC TCA CCC TCC AAA GTG 3’
EcoRI
Stop
McTnT T2
Forward: 5’ CC AAC CAT ATG CAC TTT GGA GGG TA 3’
NdeI
Reverse: 5’ G AGA ATT CTA YTT CCA RCG YCC GGT GAC 3’
EcoR1 Stop
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McTnT middle:
Forward: 5’ AG CCC CAT ATG CTC TTC ATG CCC AAC TT 3’
NdeI
Reverse: 5’ CTC TGT CTT GAA TTC TCA CCC TCC AAA GTG 3’
EcoRI
Stop
MfTnT middle:
Forward: 5’ AGA CCC AAA CAT ATG GCT CCT AAG A 3’
NdeI
Reverse: 5’ C AGC CTT GAA TTC TCA GCT GCT GTA 3’
EcoRI
Stop
Polymerase Chain Reaction (PCR)
PCR was used to amplify the cDNAs encoding TnT fragments from full length cDNAs
of TnT. Each reaction tube contained a final concentration of the following in Millipore
ddH2O: 10 fmol/ μL of the forward and reverse primer, 0.1 mM dNTP, and 20 pg/μL of the
plasmid DNA template. The amount of DNA polymerase used consisted of 90% Taq DNA
polymerase and 1 unit total of 10% pfu DNA polymerase with proofreading activity (Agilent),
to reduce the rate of PCR-introduced random mutations. PCR runs of 25 cycles were carried
out in an Applied Biosystems 2720 Thermal Cycler. The initial denaturation time at 95°C was
4 min using hot start, and each PCR cycle consisted of denaturation at 95°C for 20 s, annealing
at 55°C for 30 s and extension at 72°C for 1 min. PCR products were purified using the methods
detailed in the later section “DNA Purification”.

Figure 12 - PCR construction of McTnT T2 cDNA
from full length McTnT cDNA
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DNA Purification
In order to ensure subsequent successful restriction enzyme digestion and vector
ligation, PCR inserts and vectors were purified after restriction enzyme digestion using the
following methods:
Phenol/Chloroform Extraction
Phenol/chloroform extraction was used to inactivate and denature any protein impurities
after PCR or restriction enzyme digestion. Phenol:chloroform:isoamyl alcohol was made in a
25:24:1 ratio with a pH of 7.9 and the bottom organic layer was mixed with the DNA solution
in a 1:1 ratio. The mixture was vortexed at top speed for 20 s and then centrifuged in a
Beckman Coulter Microfuge 18 at 14,000 rpm (14,539 x g) at RT for 2 min. The DNA
containing clear aqueous phase on top was collected using a pipette and transferred into a new
tube.
Ethanol Precipitation
EtOH precipitation was used to further purify and concentrate the cDNA insert or
vector. 3M NaOAc, pH 5, was added to the DNA at 10% of the original volume. EtOH was
added to the mixture at 2.5x the volume of the NaOAc-DNA mixture. The tube was then
chilled for 10 min in dry ice and then centrifuged in a Beckman Coulter Microfuge 18 at 14,000
rpm (14,539 x g) at 4°C for 10 min. The supernatant was discarded and the pellet that contained
the DNA was washed with 100-200 μL of 75% EtOH without disturbing the pellet. The tube
was then centrifuged again as above for 2 min and the supernatant was discarded. The pellet
containing the DNA was allowed to air dry for 30 min and the pellet was resuspended in an
appropriate volume of TE buffer (10 mM Tris-HCl and 1 mM ethylenediaminetetraacetic acid
(EDTA)).
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Gel Purification of DNA Bands
To isolate the DNA product of interest, DNA bands isolated as agarose gel slices were
extracted and recovered with glass bead absorption using the Prep-A-Gene system in order to
remove any unwanted DNA and other impurities. DNA was resolved in Tris-acetate-EDTA
(TAE) agarose gel via electrophoresis at 5V/cm2. After electrophoresis, the gel was visualized
under a long wavelength UV transiluminator and the DNA band of interest was cut out using a
clean razor blade. The agarose gel piece was suspended in Prep-A-Gene binding buffer and
then melted in a 50°C water bath. After the gel piece was melted, glass beads were added to
absorb the DNA. The subsequent washes of the beads with binding and washing buffers, and
the elution of purified DNA were carried out according to the manufacturer’s protocol.
Restriction Enzyme Digestion
Restriction enzyme digestion was used to cut the expression vectors and inserts to
generate compatible sticky ends to facilitate the insertion of the PCR inserts of cDNA encoding
TnT fragments into the expression vector. Double digestion of the insert or vector was carried
out in the digestion buffer for NdeI (NEB), with 10 units each of NdeI (NEB) and EcoRI (NEB)
per μg of DNA at 37°C for 4 hr. The mixture was then purified using the methods detailed in
the Section of “DNA Purification”.
DNA Ligation
Insert and vector ligation was carried out in a 3:1 molar ratio of insert:vector, in T4
ligase buffer (NEB) using 1 μL T4 ligase (NEB) per 10 μL total reaction volume. The ligation
mixture was incubated overnight at 16°C. The ligation mixture was then used to transform (see
Bacterial Transformation section) JM109 competent E. coli cells in order to produce ampicillinresistant colonies containing the expression vector of interest with high fidelity. These colonies
were later screened using PCR for the presence of expression vector of interest.
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Figure 13 – Plasmid map of
pAED4. pAED4 was used to
express and purity untagged
proteins

Figure 14 – Plasmid
map of pTX3. pTx3
was used to purify
poorly
expressed
proteins with the aid
of the N-terminal
Tx3
(HEEAHHEEAHHE
EAH) affinity tag
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Bacterial Transformation
Transformation of JM109 or BL21 (DE3)pLysS competent E. coli cells with DNA was
used for a variety of purposes such as:
1. E. coli K12 JM109 capable of replicating target plasmid with high fidelity that could be
used for cloning the cDNA constructs followed by PCR colony screening and plasmid
minipreparation.
2. BL21(DE3)pLysS containing target plasmid for recombinant protein expression (Studier
& Moffatt, 1986).
3. BL21(DE3)pLysS expressing target protein for subsequent inoculation into culture
media for large scale protein expression and purification.
An aliquot of competent cells was put on ice until just thawed. 20 ng or more of
recombinant plasmid DNA was added to the aliquot and the mixture was swirled with the tip of
the pipet. The solution was then incubated on ice for 30 min. The tube was heat shocked at
42°C for 90 s to facilitate uptake of plasmid into the cell, and then put back on ice for 2 min.
Using proper sterile technique, LB media was added to the tube at 3-folds or more of the
volume of the cell-DNA mixture and incubated at 37°C on a rotary shaker for 45 min. During
this time, the respective Luria-Bertani Broth (LB) plate was taken out of storage and warmed up
in a 37°C incubator. For the transformation of JM109 cells, LB plates containing 100 μg/mL
ampicillin (amp) was used for selection since the pET/pAED4 vectors used in this study
contained an ampicillin resistance gene (ampR). For transformation of BL21(DE3)pLysS, LB
plates containing 100 μg/mL amp and 12.5 μg/mL chloramphenicol (chl) were used for double
selection since pLysS plasmid contained an additional chloramphenicol resistance gene (chlR).
After the 45 min. incubation, the bacteria culture was spread evenly on the LB plate and put into
the 37°C incubator. After drying out the visible liquid, the LB plate was flipped, with the lid
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facing down to avoid desiccation. The plate was then incubated at 37°C overnight for bacterial
growth.
PCR Screening of Transformed Bacterial Colonies
After ampicillin selection of the transformed JM109 cells, individual colonies were
smeared onto 100-mm LB plate containing 100 μg/mL ampicillin, divided into ~20 separate
quadrants, one for each colony and incubated at 37°C for 6 hr. Next, a sterile toothpick was
used to lightly scrape a small area of the colony smear, and then dipped into a PCR tube
containing 15 μL of a Jin lab-made Redmix PCR mix solution added with specific PCR primers
at final concentrations of 10 fmol/μL each. To screen for the recombinant plasmid containing a
specific cDNA insert by PCR, one flanking primer was placed in the vector and used together
with the other flanking primer in the target cDNA (Figure 15A). This strategy ensures that
colonies positive with a PCR amplified band indicate the presence of recombinant plasmid
containing the specific vector-insert pair (Figure 15B). The PCR steps were identical to those
mentioned in the ‘PCR’ section.
After PCR, the Redmix PCR products were directly loaded into a TBE agarose gel and
then visualized to identify colonies that had a band corresponding to the amplification of the
fragment generated by the correct vector-insert combination. Using a sterile toothpick, ~1/3 of
a positive bacterial smear was picked up and dipped into extraction solution consisting 20 l
each of phenol:chloroform:isoamyl alcohol and TE buffer. The mixture was vortexed at top
speed for 2 s and then centrifuged in a Beckman Coulter Microfuge 18 at 14,000 rpm (14,539 x
g) at RT for 2 min. The DNA in the clear aqueous phase was examined with agarose gel as
above or pipetted out and transferred into a new tube for use in the transformation of BL21 cells
for mini-protein expression screening (Figure 15B).
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Figure 15 – PCR screening of transformed bacterial colonies. (A): Linear map of the DNA
amplified from the pTx3-McTnT T2 plasmid. (B): Colony PCR screening of 7 colonies, 5
which contain the plasmid of interest.
Miniexpression and Identification of Recombinant Proteins
Phenol:chloroform:isoamyl alcohol extracted DNA from positive JM109 colonies was
used to transform BL21(DE3)pLysS competent cells in order to verify expression of the target
protein. The competent BL21(DE3)pLysS cells were transformed in a similar manner as that
described in the ‘Bacterial Transformation’ section with some modifications. A stock of 200
L competent cells was divided into 6 aliquots and each transformed with 1 L of
phenol:chloroform:isoamyl alcohol extracted DNA from different positive colonies. The tubes
were incubated on ice for 30 min and the tubes were then heat shocked at 42°C for 25 s instead
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of 90 s to account for the small volume. The addition of LB media and the incubation of the
cells were carried out as above in a standard manner. An Amp/Chl LB plate was divided into 6
quadrants to accommodate up to 6 different positive clones, and care was taken to avoid the
mixing of different competent cell aliquots on the plate. The plate was then incubated overnight
as described above in the standard conditions.
After 14 hr., 6 sterile 8.5 mL capped 13 mm glass test tubes were prepared for minicultures of the transformed E. coli. 10 mL of LB media was brought up to an ampicillin
concentration of 100 μg/mL and chloramphenicol of 25 μg/mL. 1 mL aliquots of the media was
then added to 5 culture tubes and 2 mL of was added to the last culture tube. Around 10
colonies per clone was picked from the transformation plate using an inoculating loop with
proper sterile technique and then dipped into the respective labeled culture tube. One of the
clones was randomly chosen to inoculate into the culture tube containing 2 mL LB media as a
control. The inoculated bacterial cultures were grown at 37°C in a shaking incubator at 200
rpm. After 45 min. of bacterial growth, at which the culture tubes started to appear slightly
cloudy, 1 mL of the control tube was separated into a clean empty tube as the uninduced
control. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the final concentration of
0.4 mM to all other 6 culture tubes (excluding the control tube) and grown for an additional 3
hr. to induce protein production.
The induced bacterial cultures were then transferred to clean 1.5 mL eppendorf tubes
and centrifuged in a Beckman Coulter Microfuge 18 at 14,000 rpm (14,539 x g) for 5 min. to
harvest the cells. The supernatant was discarded and 100-300 μL of 1x SDS-sample buffer was
added to the pellet according to pellet size. The bacterial pellets were then sonicated and heated
at 80°C for 5 min to extract the total proteins and break up the bacterial genomic DNA. SDSPAGE and western blot were then run to determine the level of the expression of the TnT or
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TnT fragment, with the uninduced control included to help identification of the target protein in
the SDS-PAGE gel and western blot. A clone with the best protein expression would later be
used for minipreparation of plasmid DNA for sequencing confirmation of the expression
plasmid construct.
Plasmid Minipreparation
After the best clone was determined by miniexpression, the corresponding JM109 smear
culture identified by the colony PCR screening was used to inoculate in a 50 mL tube with 5 mL
of LB media brought up to a final ampicillin concentration of 100 μg/mL. The culture was
inoculated using an inoculating loop by lightly touching a colony from the smear and dipping
into the media. The bacterial culture was then incubated for 12 hr. at 37°C in a shaking
incubator at 200 rpm. After incubation, the 50 mL tube was spun down in a Beckman GS-6R
centrifuge with a GH-3.8 rotor at 3,000 rpm (1,459 x g) for 15 min. The supernatant was
discarded and the tube was inverted on a paper towel to get rid of any excess supernatant. The
plasmid DNA from the pellet was then purified using the GenElute™ Plasmid Miniprep Kit
(Sigma) according to the manufacturer’s instructions. Briefly, the pellet was suspended in
RNAse A solution, lysed in an SDS-alkali solution, and neutralized with binding solution. The
mixture was spun to remove cell debris, proteins, lipids, SDS, and chromosomal DNA, which
all appear in a viscous precipitate. The supernatant was then added to a silica spin column to
absorb the plasmid DNA, followed by elution with TE buffer. The purified DNA is then
analyzed using agarose gel electrophoresis to confirm the presence of the target plasmid and is
then sent for DNA sequencing at a commercial service facility (GENEWIZ).
DNA Sequence Analysis
To confirm the identity of the plasmid containing the target insert, an aliquot of the
purified plasmid was sent to GENEWIZ for sequencing, using the T7 forward primer and T7
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terminator reverse primer that flank the cDNA insert cloned into the pET or pAED4 plasmids.
The chromatograph trace generated from DNA sequencing via capillary electrophoresis was
checked to ensure the sequence was clean with minimal background noise, indicating high
plasmid quality. Any miscalled nucleotides and dye blots in the trace was corrected before
finalizing the DNA sequence. The coding sequence was then translated into the amino acid
sequence using DNASTAR Lasergene and the amino acid sequence was compared to the
reference sequence in the database to confirm a 100% match.
Large Scale Protein Expression and Purification
Large Scale Expression of Recombinant Troponin T and Fragments
BL21(DE3)pLysS cells were transformed in the afternoon with recombinant plasmid
containing the cDNA of interest on two 100-mm Amp/Chl plates and incubated at 37°C
overnight. In the next morning, Amp and Chl was added to 8 flasks of 1 L previously prepared
autoclaved LB media, to the final concentrations of 100 μg/mL and 12.5 μg/mL respectively. A
2 mL aliquot of the LB media was used as blank for spectrometry measurements of bacterial
growth. A 20 mL aliquot of the LB media was transferred to a 50 mL sterile culture tube. The
BL21(DE3)pLysS cells were scraped off the LB plate with a glass spreader and suspended in
the 20 mL aliquot of LB. The bacterial cell suspension was pipetted up and down to ensure
homogeneity and then distributed evenly to each flask. The flasks were then incubated in a
37°C incubator and shaken at 200 rpm. Bacterial growth in the culture flask was monitored by
measuring OD600. When the OD600 reached 0.3, a 1 mL aliquot from one of the bacterial culture
flasks was taken and the cells were spun down in a Beckman Coulter Microfuge 18 at 14,000
rpm (14,539 x g) to serve as an uninduced control. The bacterial cultures were then induced by
adding IPTG to a final concentration of 0.4 mM. The cultures were shaken at 37°C for an
additional 3 hr. for the induction of protein expression. After the protein induction phase, OD600
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measurements of the cultures were recorded and 1 mL samples of bacterial cultures were taken
for collecting cells and evaluating the protein expression using SDS-PAGE and western blot.
The bacterial cultures were transferred to 1 L centrifuge bottles and centrifuged at 8,000
rpm (12,228 x g) for 15 min in a Beckman Coulter Avanti J-20 XPI using a JLA 8.1 rotor.
After centrifugation, the supernatant was discarded. The bacterial pellets were put on ice,
combined together and suspended in lysis buffer (50 mM, 5 mM EDTA pH 8.0), supplemented
with 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 15 mM β-mercaptoethanol to a final
volume of 100 mL. The bacterial cell suspension was then lysed using a French press at >500
psi for 3 passes. The lysate solution was then centrifuged at 12,000 rpm (13,845 x g) in a JA-14
rotor for 30 min to remove cell debris. 0.1 mL of the supernatant was kept for SDS-PAGE and
western blot analysis of total protein expression.
Ammonium-Sulfate Precipitation
Ammonium sulfate precipitation is used for the fractionation of proteins by altering
protein solubility though changes in ionic strength. Ammonium sulfate was added to the
protein solution with step wise increments in concentration and the precipitate fractions were
collected separately. The amount of (NH4)2SO4 needed to bring up the protein solution to the
desired saturation level at 0°C was calculated according to standard technical manuals. The
protein solution was kept on ice and stirred while slowly adding the desired amount of solid
(NH4)2SO4. After adding (NH4)2SO4, the solution was stirred on ice for 20 min. to reach
equilibrium. The solution was then centrifuged at 12,000 rpm (13,845 x g) in a JA-14 rotor for
30 min. The supernatant was separated and a sample of the supernatant and pellet was taken for
dialysis and SDS-PAGE/western blot analysis to evaluate the enrichment of the recombinant
TnT protein. The supernatant was measured for actual volume, subsequently brought up to a
higher saturation of (NH4)2SO4 and the previous steps were repeated to separate the next
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supernatant and pellet. Although the optimum (NH4)2SO4 steps were later determined and finetuned experimentally, initial steps were collecting pellet of 0-20%, 20-40% and 60-80% in a
new protein purification protocol. The precipitate and supernatant fractions were dialyzed
overnight with three changes.

The next day, SDS-PAGE and Western blot results were

evaluated and the fraction containing the protein of interest was loaded into the column for
further purification.

Figure 16 – SDS-PAGE and Western blot of the expression of MsTnT
Dialysis
For dialysis of protein samples, Fisherbrand regenerated cellulose dialysis tubing with a
molecular weight cut off (MWCO) of 6,000-8,000 daltons was used. In order to dialysis
ammonium sulfate precipitation fractions, the pellets were dissolved in a minimum amount of
dialysis buffer (cold ddH2O with 0.1 mM EDTA and 0.1% formic acid). The solution was then
transferred into the dialysis tubing and the ends were clamped. The dialysis bags were then put
into a container of dialysis buffer to ensure a volume ratio of 100:1 or larger of the buffer to the
dialysis tubing volume. The dialysis container was kept stirring in 4°C for 4 hours or longer
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between changes to ensure equilibrium between the dialysis tubing and the dialysis container.
The supernatant samples were dialyzed directly
Column Chromatography
Anion Exchange Chromatography
This technique separates proteins based on varying charge of proteins, in which protein
solution (the liquid phase) is passed through a covalently cross-linked ion-agarose beads matrix
(the solid phase). In the present study, the solid phase is comprised of positively charged
diethylaminoethyl cellulose (DE52) beads. In order for the target protein to bind to the beads,
the proteins must be negatively charged. This requires the pH of the column to be at least 1 unit
higher than the PI of the target protein. Elution of proteins bound to the column is achieved by
increasing ionic strength through an increasing gradient of KCl. The more tightly bound
proteins elute out towards the end of the gradient, where a higher ionic strength is required to
disrupt its interactions with the column beads.
A 50 mL DE52 column was first regenerated using a BioLogic LP system with the
following steps:
1.

1 M KCl

20 mL

2.

ddH2O

50 mL

3.

1 M HCl

20 mL

4.

1 M NaOH

20 mL

5.

ddH2O

Until pH 7

6.

1 M Buffer A (pH depends on protein)

Until target pH reached (~10 mL)

7.

Buffer A

Until target pH and conductivity reached

Buffer A: With or without 6 M urea (for insoluble/soluble proteins), 10 mM Tris-HCl pH
adjusted to target protein of interest. Buffer B: DE52: Buffer A + 300 mM KCl (adjust pH) .
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Steps 6 and 7 were used to equilibrate the column beads to the desired pH for the run to
ensure optimum separation of the target protein. The protein solution was brought up to 6 M
urea in the cases of insoluble proteins in Buffer A supplemented with 0.5 mM PMSF, 0.1 mM
EDTA (for inhibition of any proteases). The protein solution was centrifuged using a JA-14
rotor at 12,000 rpom for 30 minutes. 15 mM β –Mercaptoethanol was added to the protein
sample and 6 mM β –Mercaptoethanol was added to the column buffers. The protein solution
was then loaded into the column and the following program was run through the BioLogic LP
system at a flow of 1 mL/min for all steps:
1

Buffer C

100 min (Assuming sample size is 100 mL)

2.

Buffer A

50 min

3.

Buffer B

300 min

4.

Buffer B 0-100%

50 min

Fraction collection

6 min per fraction, collect 56 min to 530 min

The outflow of the column was monitored using an in line UV monitor for absorbance at
280 nm. SDS-PAGE and western blots were run for the protein containing fractions to evaluate
the peak fraction containing the target protein.

Those fractions were then dialyzed and

lyophilized. An example of the DE52 column profile is shown in Figure 17.
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Figure 17 – DE52 anion exchange column purification of MsTnT. (A): MsTnT starts to elute at
fraction 22 and ends at fraction 31. (B): Higher molecular weight contaminant proteins eluting
at higher concentrations of KCl
Size-exclusion Chromatography
In order to further separate impure protein fractions by size, a 2.5 x 120 cm (588 mL)
G75 gel filtration column was used. The G75 column was first washed using a BioLogic LP
system with one column volume equivalent of the buffer containing 6 M urea, 0.5 M KCl, 10
mM imidazole, 0.1 mM EDTA, pH 7.0, and supplemented with 6 mM β –mercaptoethanol
(“G75 buffer”) at a flow rate of 0.5 mL/min. The lyophilized protein to be loaded into the
column was dissolved in a minimum volume of G75 buffer (<5 mL when possible). The
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protein sample solution was centrifuged in a Beckman Coulter Microfuge 18 at 12,000 RPM
(10,682 x g) for 5 minutes and loaded onto the G75 column. The following program was run
with BioLogic LP system:
Flow rate set to 0.5 mL/min
1. G75 Buffer
Fraction collection

1280 min
12-16 min per fraction, collect 200 to 1280 min

The column fractions were monitored using a UV monitor at 280 nm. SDS-PAGE and
Western blot of the fractions were run to evaluate which fraction contained the target protein at
the highest amount and purity. Those fractions were then dialyzed and lyophilized.

Figure 18 – G75 Size exclusion column
purification of MsTnT. Pure fractions of
MsTnT starts to elute at fraction 24 and
ends at fraction 27

Metal Ion Affinity Chromatography
High efficiency metal ion affinity chromatography was used to purify TnT fragments
that expressed in E. coli only at very low levels. cDNAs encoding the TnT fragments were
cloned into a modified plasmid vector encoding an N-terminal affinity tag, Tx3
(HEEAHHEEAHHEEAH), to facilitate the purification via metal ion affinity chromatography.
This repeating Tx sequence is a metal binding cluster that has been naturally found in fTnT in
chicken breast muscle, which indicates that this sequence is well tolerated in TnT (Jin &
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Smillie, 1994). The use of Tx sequence as an affinity purification tag allows for highly
effective purification of the target protein using a Zn(II) column in high stringency buffer
conditions (e.g., 6 M urea, 1 M KCl), which demonstrate the greater effectiveness of Tx3 tag
over the commonly used polyhistidine tags (Jin & Lin, 1988; Arnold & Haymore, 1991; Ogut &
Jin, 1996; Jin et al., 2000).
The column used for this procedure was a 20 mL column containing Chelating
Sepharose Fast Flow beads (GE Healthcare). The column was first regenerated and charged
with Zn2+ in the following manner:
1.

10 mM EDTA in 1 M KCl

20 mL

2.

ddH2O

50 mL

3.

0.1M NaOAc (pH 4.0)

20 mL

4.

0.1M ZnCl2 in 0.1 NaoAc (pH 4)

20 mL

5.

0.1M NaOAc (pH 4.0)

20 mL

6.

ddH2O

20 mL

7.

0.1 M phosphate buffer (pH 7.4)

20 mL

8.

Lysis buffer (pH 7.4)

20 mL

During this procedure, competent cells were transformed and protein was expressed as
described above. After centrifuging the bacterial cultures, the bacterial pellets were combined
and suspended in a urea lysis buffer (6 M urea, 1 M KCl and 20 mM phosphate buffer, pH 7.4)
or non-urea low salt lysis buffer (30 mM KCl, 20 mM phosphate buffer, pH 7.4). In the present
study, only Tx3-McTnT T1 required the use of the non-urea lysis buffer as it had weaker
binding in the urea lysis buffer.
After suspending the bacterial pellet in lysis buffer and lysis of cells using French press
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as above, the lysate was centrifuged using a JA-14 at 12,000 RPM (13,845 x g) for 30 min. and
the supernatant was loaded into an equilibrated Zn2+ column. After the flowthrough was
collected, the column was washed with 100 mL of lysis buffer. The column was then eluted
with 1 column volume each step of increasing concentrations of imidazole (10 mM to 100 mM)
to elute the metal-binding recombinant TnT fragment. The peak fractions were identified with
SDS-PAGE and Western blot, dialyzed, and lyophilized.
Figure 19 – SDS-PAGE
and Western blot of Zn2+
affinity
column
purification of Tx3-MfTnT
middle fragment. Pure
fractions of the fragment
elute from 2 mM to 60 mM
imidazole with bacterial
protein
contaminants
eluting
during
the
flowthrough and washing
step.

SDS‐PAGE 12% (29:1)

Lyophilization of Protein Samples
Protein samples were lyophilized using a Labconco FreeZone 4.5 Liter system. After
fully dialyzed, the protein solutions were frozen in a dry ice box for 45 min while positioned to
achieve a large surface area. The flasks were then quickly connected to the drying chamber of
the lyophilizer for freeze-drying.
Tropomyosin Binding Assay
Solid-Phase Microplate Protein-Binding Assay
The tropomyosin binding assay used in the present study is an ELISA-based solid-phase
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microplate protein-binding assay which takes advantage of immunological detection in a high
throughput plate form to assess the tropomyosin binding affinities of different TnT constructs
(Biesiadecki & Jin, 2011).
TnT was coated and immobilized non-covalently on a polystyrene microtiter plate while
the binding partner applied to TnT was rabbit α/β skeletal muscle tropomyosin previously
prepared in Dr. Jin’s laboratory (Smillie, 1982). The primary antibody applied to detect the
bound tropomyosin was a monoclonal antibody against both of the muscle Tm isoforms (Lin,
Chou, & Lin, 1985). The binding of Tm to different TnT constructs was elucidated by the
binding of Tm at a series of concentrations and different amounts of Tm left binding to TnT
after stringent washes.

The difference in Tm binding is quantitatively determined by

colorimetric reaction via the use of Horseradish peroxidase (HRP)-labeled second antibody.
Thus, this assay gives information regarding binding affinity and binding strength between the
two proteins, Tm and TnT.
The purified TnT proteins were dissolved in Buffer A (100 mM KCl, 1 mM ethylene
glycol tetraacetic acid (EGTA), 3 mM MgCl2, 20 mM piperazine-N,N0-bis(2-ethanesulfonic
acid) (PIPES), pH 7.0) at 5 μg/mL to coat 96-well polystyrene microtiter plates at 100 μL/well
at 4°C overnight. Free TnT proteins were removed by washing with Buffer T (Buffer A plus
0.05% Tween 20) for three times over a 10 min. period. The plate was then blocked with
Buffer T + 1% BSA at room temperature for 1 hr. Serial dilutions of rabbit α/β skeletal muscle
tropomyosin in Buffer T containing 0.1% BSA were added to the plate at 100 μL/well and
incubated at room temperature for 2 hr. The plates were washed three times with Buffer T and
an anti-Tm mAb CH1 (1:10,000) was added to the plate at 100 μL/well and incubated at room
temperature for 1 hr.

After three Buffer T washes, goat anti-mouse HRP-labeled second

antibody (1:4,500) was added to the plate at 100 μL/well and incubated at room temperature for
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45 min. After three Buffer T washes, the amount of Tm bound to the immobilized TnT in each
well was quantified using H2O2–ABTS (2,20-azinobis(3-ethylbenzthiazoline-6-sulfonic acid)
substrate reaction catalyzed by HRP. The A415nm values in the linear course of the color
development were monitored for each assay well against the reference wavelength of 655 nm
using a Bio-Rad Benchmark automated microplate reader and recorded to construct Tm-binding
curves for each set of TnT proteins. The experiments were done in triplicate wells and repeated.
Statistical Analysis
The raw absorbance values of each binding curve were compared via repeated measures
using two-way ANOVA using GraphPad Prism software. The column means were compared
across raw data binding curves and a Tukey’s multiple comparisons test was conducted with a
0.05 significance level.
In order to obtain 50% maximum binding values, sigmoidal dose-response (variable
slope) curves were fitted to each binding curve with the least squares fitting method.
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Figure 20 - ELISA-based solid-phase protein binding assay
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CHAPTER 3
RESULTS
Tropomyosin Binding Affinity of T2 Fragments of Different TnT Isoforms
There was no significant difference in Tm binding affinity among the muscle fiberspecific T2 fragments. These fragments are comprised of their respective T2 binding regions,
which have the site 2 Tm binding site.

Figure 21 – No significant differences in Tm binding affinity between T2 fragments across
isoforms. (P=0.8480 for cardiac T2 vs. slow T2, P=0.9895 for fast T2 vs. slow T2 by Fisher test
in Two Way ANOVA).
Tropomyosin Binding Affinity of T1 Fragments of Different TnT Isoforms
There was a significant difference in Tm binding affinity among the T1 fragments of
different muscle fiber-specific isoforms, with fast T1 having the highest Tm binding affinity,
then cardiac and lastly slow T1 with the lowest Tm binding affinity. These fragments are
comprised of their respective N-terminal hypervariable regions and middle conserved regions,
which contain the Tm binding site 1.
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Figure 22 – Significant differences in Tm binding affinity between T1 fragments across
isoforms. (****P < 0.0001 for cardiac T1 vs. slow T1, ****P < 0.0001 for fast T1 vs. slow T1
by Fisher test in Two Way ANOVA)
Tropomyosin Binding Affinity of Middle Fragments of Different TnT Isoforms
There was no significant difference in Tm binding affinity between the middle
fragments among different muscle-fiber specific isoforms. These fragments are comprised of
their conserved middle regions, which lack their respective N-terminal hypervariable regions
but retain the site 1 Tm binding site.
Figure 23 - No significant
differences in Tm binding
affinity
between
middle
fragments across isoforms.
(P=0.9814 for cardiac middle
vs. slow middle, P=0.0538 for
fast middle vs. slow middle by
Fisher test in Two Way
ANOVA)
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Tropomyosin Binding Affinity of Intact TnT Isoforms
There was a significant difference in Tm binding affinity among the intact TnTs of
different muscle fiber-specific isoforms, with fast TnT having the highest Tm binding affinity,
then cardiac and lastly slow TnT with the lowest Tm binding affinity. These TnTs are
comprised of their respective T1 and T2 regions which each contain Tm binding sites 1 and 2,
respectively.

Figure 24 - Significant
differences
in
Tm
binding affinity between
intact TnT isoforms.
(****P < 0.0001 for
cardiac intact vs. slow
intact, ****P < 0.0001
for fast intact vs. slow
intact by Fisher test in
Two Way ANOVA)

Tropomyosin Binding Affinity of TnT Comparison within Species and Isoform
Intact cardiac TnT had the highest Tm binding affinity, followed by the cardiac middle
and T2 fragments, which contain the Tm binding site 1 and 2, respectively (these two did not
have significantly different Tm binding). The cardiac T1 fragment had the lowest Tm binding
affinity, and contained its respective N-terminal hypervariable region and site 1 Tm binding
site.
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Figure 25 - Comparison of Tm
binding affinity of intact, T1,
T2 and middle fragments of
cardiac TnT. There were
significant differences in Tm
binding affinity between T2, T1
and intact, with no significant
difference between middle and
T2; all TnTs are within the
same species and isoform. (**P
< 0.0026 for cardiac intact vs.
cardiac T2, ****P < 0.0001 for
cardiac T1 vs. cardiac T2, and
P=0.4978 for cardiac middle vs.
T2 by Fisher test in Two Way
ANOVA)
Below is a summary of each set of ELISA experiments. In the Table, Tm binding refers
to the qualitative difference of Tm binding, where Ref is the reference curve used for
comparison, and + and - represent an increase and decrease in Tm binding, respectively. EC50
values are the Tm concentrations to reach 50% maximum Tm binding for each TnT construct.
Table 2 – Summary of Protein Binding Experiments
TnT Fragment
Tm Binding
EC50
Std. Dev.

Cardiac T2
=
2.279E-08

Slow T2
Ref
2.443E-08

Fast T2
=
2.545E-08

0.01687

0.01546

0.01593

TnT Fragment
Tm Binding
EC50
Std. Dev.
TnT Fragment
Tm Binding
EC50
Std. Dev.

Cardiac T1
+
3.338E-08
0.02425
Cardiac Middle
=
2.481E-08
0.01482

Slow T1
Ref
5.103E-08
0.03049
Slow Middle
Ref
2.744E-08
0.01392

Fast T1
++
2.491E-08
0.03195
Fast Middle
=
2.301E-08
0.01428

TnT Fragment
Tm Binding
EC50
Std. Dev.

Cardiac Intact
+
1.606E-08
0.009816

Slow Intact
Ref
2.007E-08
0.01101

Fast Intact
++
1.283E-08
0.009500

TnT/TnT Fragment
Tm Binding
EC50
Std. Dev.

Cardiac Intact
+
1.630E-08
0.01243

Cardiac T1
3.213E-08
0.01825

Cardiac Middle
=
2.707E-08
0.01350

Cardiac T2
Ref
2.270E-08
0.01721
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CHAPTER 4
DISCUSSION
Methodology and Rationale
This is the first study that has compared intact TnTs and TnT fragments in order to
elucidate the differences in intrinsic site 1 and site 2 Tm binding affinity across muscle fiberspecific isoforms. Previous studies that investigated TnT’s Tm binding affinity have relied on
enzymatic and chemical cleavage of intact TnT to generate various fragments that contain or
lack specific TnT Tm binding sites (Mak & Smillie, 1981; Nakamura, Yamamoto, Hashimoto,
& Ohtsuki, 1981; Pearlstone & Smillie, 1982; Heeley et al., 1987; Jin et al., 2000). In this
study, molecular biology techniques were used to generate intact TnT and TnT fragments that
allowed comparison and elucidation of the structure and function of TnT beyond the
conventional comparison of the T1 and T2 regions of TnT. These two regions produced by
enzymatic or chemical cleavage have been useful to investigate the Tm binding affinity of T1
and T2 regions. However, this approach was not particularly useful to understand the intrinsic
Tm binding affinity of site 1 which was further explored in this study. The expression and
purification of TnT fragments with the aid of affinity tag chromatography has allowed further
investigation into the role of TnT’s Tm binding sites and the role of the N-terminal
hypervariable region in the modulation of TnT-Tm binding
The Role of TnT’s N-Terminal Hypervariable Region in Muscle Fiber-Specific Isoforms
One of the main findings in this study is that TnT’s N-terminal hypervariable region is
responsible for the significant differences in tropomyosin binding across muscle-fiber specific
isoforms.
When the T1 fragments among different muscle fiber-specific isoforms are compared,
there is a significant difference in Tm binding (Figure 22). Among the T1 fragments across
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isoforms, fast TnT was observed to have the highest binding affinity to Tm, followed by cardiac
and then slow. This pattern was also observed in the intact TnT, with significant differences
across intact TnT isoforms (Figure 24). Since the T1 fragments only contain their respective Nterminal hypervariable region in addition to the highly conserved middle Tm binding site 1, the
presence of this N-terminal hypervariable region is responsible for variably modulating site 1’s
Tm binding affinity across isoforms, both in intact TnTs and TnT T1 fragments of muscle fiberspecific isoforms.
It is important to note that this significant differences in Tm binding affinity in intact
TnTs is not decreased with the presence of both Tm binding sites despite this study’s
observation that there is no significant difference in site 2’s binding affinity across isoforms
(Figure 21). The observation that the significant differences in intact TnT isoforms are still
present despite the similar Tm binding affinity of site 2 across muscle specific isoforms indicate
that the differences in TnT isoforms arise because of the modulation site 1’s Tm binding affinity
by the N-terminal hypervariable region.
When the N-terminal hypervariable region is removed and only the middle region of
TnT is compared across isoforms, the significant difference in site 1 Tm binding affinity is
abolished (Figure 23). This indicates that the difference in site 1’s Tm binding affinity among
the T1 fragments across isoforms is due to the presence of the N-terminal hypervariable region.
This observation is consistent with previous data showing that the N-terminal hypervariable
region not only alters TnT’s overall conformation, but most likely modulates the more proximal
central Tm-binding site as opposed to the more distal TnT binding site (J. Wang & Jin, 1998;
Jin et al., 2000).
Additionally, this study also corroborated previous observations that the N-terminal
truncation of cTnT results in an overall increase in intact TnT’s binding affinity to Tm (Fisher et
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al., 1995; Feng et al., 2008). The mechanism of this phenomenon is more apparently in this
study, where it was shown that the cTnT middle fragment exhibited a higher Tm binding
affinity than the T1 fragment (Figure 25). This indicates that the N-terminal truncation of intact
cardiac TnT results in an overall increase of Tm binding largely due to the lack of modulation
of site 1’s Tm binding affinity by the N-terminal hypervariable region.
Tm Binding Affinity of Sites 1 and 2
This study also evaluated the Tm binding affinity of each site across isoforms as well as
within a specific isoform and species. T2 fragments had an overall higher Tm binding affinity
compared to the T1 fragments (Figure 25). This is in line with previous observations decades
ago showing that the fTnT T2 has the greater Tm binding affinity compared to fTnT T1 when
both proteins are analyzed on an α-tropomyosin binding column (Heeley et al., 1987).
Although this study used α-β tropomyosin in the binding assays, previous studies have
shown that the TnT fragments do not each have their own “specific preference” in regards to
Tm binding affinity. Instead, it was observed that TnT fragments and intact TnT all exhibit a
higher binding affinity to α- tropomyosin and a lower binding β- tropomyosin. Because of this
observation, the conclusions reached in this study regarding Tm binding affinity of TnT
fragments would most likely hold if α-tropomyosin or β-tropomyosin was used (Heeley et al.,
1987).
In the experiment comparing intact TnT and TnT fragments within the same isoform and
species, the middle cTnT fragment’s binding affinity was not significantly different compared
to cTnT T2. This indicates that without the modulatory effect of the N-terminal hypervariable
region, the intrinsic Tm binding affinity of site 1 is not significantly different to site 2’s Tm
binding affinity, and that Tm binding affinity of both sites is high (Figure 25).

This is

demonstrated by the observation that the T2 fragments across isoforms exhibit no significant
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differences in binding affinity to tropomyosin while the T1 fragments across isoforms exhibit
significant differences in binding affinity to tropomyosin due to their respective N-terminal
hypervariable region.
Conclusions
This study demonstrated that N-terminal variable region is a regulatory structure for
functional alteration of TnT muscle fiber-specific isoforms. In the absence of the N-terminal
variable region of TnT, TnT’s conserved site 1 and site 2 tropomyosin binding sites across
isoforms do not have any significant difference in Tm binding affinity (Figure 25). This
indicates that the N-terminal hypervariable region is largely responsible for the functional
difference of TnT across isoforms by variably modulating the Tm binding affinity of site 1. A
discrepancy in past literature (Pearlstone & Smillie, 1982; Heeley et al., 1987; Jin & Chong,
2010) showing different Tm binding of T1 fragments vs. T2 Tm binding is explained by the
data in this study by demonstrating that site 1’s Tm binding affinity is differentially modulated
by the N-terminal hypervariable region across isoforms (Figure 26).
This difference in modulation of site 1 and possibly site 2 is largely responsible for
altering the overall conformation of TnT and thus conformation of the troponin complex (Figure
26), which subsequently modulates the calcium activated regulation of striated muscle
contraction (Ebashi & Endo, 1968; Meinrenken, 1969; Gazith et al., 1970; Spudich & Watt,
1971; Mihashi, 1972; Vaneerd & Kawasaki, 1973; Rupp, 1983; Biesiadecki et al., 2007; Sheng
& Jin, 2014), and thus plays a role in the functional difference of muscle fiber type-specific,
developmental, splice variant, and pathogenic TnT isoforms.
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Figure 26 – A model summarizing the findings. The N-terminal hypervariable region
modulates the Tm binding affinity of Tropomyosin Binding Site 1 and thus results in variable
Tm binding affinity of Site 1 across TnT muscle fiber specific isoforms. The partial high
resolution structure of the Troponin complex was redrawn from previously published
crystallography data (Takeda et al., 2003; Vinogradova et al., 2005; Sheng & Jin, 2014)
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The troponin complex plays a central role in the allosteric function of sarcomeric thin
filaments by enacting conformational changes during the Ca2+-regulated contraction and
relaxation of striated muscle.

The troponin subunit T (TnT) has two binding sites for

tropomyosin (Tm) and is responsible for anchoring the troponin complex to the thin filament.
Although the C-terminal and middle regions of the TnT polypeptide chain are highly conserved
among the three muscle type isoforms, the hypervariable N-terminal region has evolutionarily
diverged significantly among isoforms.

Previous studies have shown that the N-terminal

variable region fine-tunes Ca2+ regulation of muscle contractility via modulation of the overall
molecular conformation of TnT, and its interactions with Tm. In the present study, intact TnT
and representative TnT fragments were engineered, and expressed in E. coli. The TnT proteins
were then purified using various biochemical and chromatographic techniques and prepared for
functional studies.

Tropomyosin binding affinity was analyzed using solid phase protein

binding assays to investigate the modulatory effects of the N-terminal variable region. The
results demonstrated that in the absence of the N-terminal variable region, TnT’s conserved
middle region and C-terminal T2 region Tm-binding sites showed comparable Tm-binding
affinities across isoforms. The data demonstrate that without the modulatory effect of the N-
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terminal variable region, the intrinsic Tm-binding affinities of the two sites are both high. In
contrast, the presence of the isoform specific N-terminal variable region differentially reduces
the binding affinity of TnT for Tm, primarily at the middle region binding site. These novel
findings indicate that the N-terminal variable region plays a key role in the functional difference
of muscle fiber type-specific, developmental, splice variant, and pathogenic TnT isoforms by
modulating the interactions with Tm during the contraction and relaxation of cardiac and
skeletal muscle.
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